Zhengquan Wu

715 total citations
12 papers, 447 citations indexed

About

Zhengquan Wu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhengquan Wu has authored 12 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhengquan Wu's work include Cancer-related molecular mechanisms research (4 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zhengquan Wu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Prostate Cancer Treatment and Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zhengquan Wu collaborates with scholars based in China, Germany and Slovakia. Zhengquan Wu's co-authors include Yuhu Dai, Chuandong Lang, Dong Ren, Xinsheng Peng, Qing Yang, Hong Du, Wei Guo, Shaofu He, Yue Li and Kai‐Yuan Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Mineral Research and Frontiers in Immunology.

In The Last Decade

Zhengquan Wu

12 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengquan Wu China 10 323 227 74 68 45 12 447
Xuejing Zou China 12 504 1.6× 407 1.8× 56 0.8× 61 0.9× 32 0.7× 26 672
Justin Hartke United States 2 275 0.9× 210 0.9× 103 1.4× 68 1.0× 43 1.0× 3 484
Guangquan Xu China 8 495 1.5× 323 1.4× 82 1.1× 57 0.8× 92 2.0× 10 641
Zhenqing Sun China 13 254 0.8× 123 0.5× 60 0.8× 109 1.6× 60 1.3× 22 445
Ziyi Zhao China 13 338 1.0× 183 0.8× 73 1.0× 77 1.1× 39 0.9× 50 505
Lixian Zeng China 11 412 1.3× 224 1.0× 49 0.7× 64 0.9× 21 0.5× 18 552
Songhan Li China 7 217 0.7× 129 0.6× 42 0.6× 86 1.3× 41 0.9× 14 375
Erfei Chen China 12 265 0.8× 188 0.8× 46 0.6× 90 1.3× 20 0.4× 25 404

Countries citing papers authored by Zhengquan Wu

Since Specialization
Citations

This map shows the geographic impact of Zhengquan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengquan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengquan Wu more than expected).

Fields of papers citing papers by Zhengquan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengquan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengquan Wu. The network helps show where Zhengquan Wu may publish in the future.

Co-authorship network of co-authors of Zhengquan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengquan Wu. A scholar is included among the top collaborators of Zhengquan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengquan Wu. Zhengquan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wu, Zhengquan, Sabina Schwenk‐Zieger, Gisela Kranz, et al.. (2023). 5ʹ-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells. Journal of Biomedical Science. 30(1). 72–72. 9 indexed citations
2.
Wang, Min, Zhengquan Wu, Xinwen Wang, et al.. (2023). The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1/DDX3X complex in Wnt/β-catenin signaling. Cell Death Discovery. 9(1). 287–287. 9 indexed citations
3.
Wu, Zhengquan, Bernd Uhl, Olivier Gires, & Christoph A. Reichel. (2023). A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence. Journal of Biomedical Science. 30(1). 21–21. 41 indexed citations
4.
5.
6.
Lang, Chuandong, Kai‐Yuan Lin, Yue Li, et al.. (2021). m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization. SHILAP Revista de lepidopterología. 11(6). e426–e426. 118 indexed citations
7.
Popp, Vanessa, Lisa Seyler, Katerina Kachler, et al.. (2020). Systemic PPARγ Antagonism Reduces Metastatic Tumor Progression in Adipocyte-Rich Bone in Excess Weight Male Rodents. Journal of Bone and Mineral Research. 36(12). 2440–2452. 10 indexed citations
8.
Lang, Chuandong, Yuhu Dai, Zhengquan Wu, et al.. (2020). SMAD3/SP1 complex‐mediated constitutive active loop between lncRNA PCAT7 and TGF‐β signaling promotes prostate cancer bone metastasis. Molecular Oncology. 14(4). 808–828. 66 indexed citations
9.
Yang, Qing, Chuandong Lang, Zhengquan Wu, et al.. (2019). MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 391–391. 54 indexed citations
10.
Dai, Yuhu, Zhengquan Wu, Chuandong Lang, et al.. (2019). Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. Theranostics. 9(21). 6063–6079. 54 indexed citations
11.
12.
Wu, Zhengquan, et al.. (1987). Distribution of lead in renal proximal convoluted tubules of lead‐poisoned rats. Journal of Electron Microscopy Technique. 7(2). 91–95. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuejing Zou Breakdown of academic impact, for papers by Justin Hartke Breakdown of academic impact, for papers by Guangquan Xu Breakdown of academic impact, for papers by Zhenqing Sun Breakdown of academic impact, for papers by Ziyi Zhao Breakdown of academic impact, for papers by Lixian Zeng Breakdown of academic impact, for papers by Songhan Li Breakdown of academic impact, for papers by Erfei Chen
Rankless by CCL
2026